Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT04881682

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Led by University of Ulm · Updated on 2026-05-01

20

Participants Needed

1

Research Sites

252 weeks

Total Duration

On this page

Sponsors

U

University of Ulm

Lead Sponsor

M

Miltenyi Biomedicine GmbH

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a randomized controlled study evaluating safety and efficacy of repeated immunoadsorption versus immunoglobulins in steroid-refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

CONDITIONS

Official Title

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of possible, probable, or definite CIDP (typical or atypical) according to EFNS guidelines
  • Disease duration of 3 years or less
  • Age 18 years or above
  • Previous treatment with methyl-prednisolone and insufficient therapeutic response as judged by the treating physician, or contraindications against methyl-prednisolone, or clinically significant side effects under methyl-prednisolone therapy as judged by the treating physician
Not Eligible

You will not qualify if you...

  • Clinical or laboratory evidence of manifest systemic infection, such as C-reactive protein (CRP) above 20 mg/l or nitrite-positive urinary tract infection
  • Intake of angiotensin converting enzyme inhibitor within 1 week before first treatment
  • Immunoglobulin A deficiency
  • Other contraindications against immunoadsorption or intravenous immunoglobulins

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Neurology, University of Ulm

Ulm, Baden-Wurttemberg, Germany, 89081

Actively Recruiting

Loading map...

Research Team

J

Johannes Dorst, Prof

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here